サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1464059

細胞溶解と分画の世界市場レポート 2024年

Cell Lysis And Fractionation Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
細胞溶解と分画の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

細胞溶解と分画市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR7.5％で45億7,000万米ドルドルに成長します。予測期間中に予想される拡大は、個別化医療への注目の高まり、研究に対する政府資金の増強、効率的な調査技術への大きな需要、ゲノミクスとプロテオミクスの技術的進歩、慢性疾患と感染症の蔓延の高まりが原動力となっています。予測期間中に予想される重要な動向には、個別化医療手法の採用における持続的な成長、溶解・分画手順における自動化・ロボット化の拡大、臨床診断や医薬品開発における用途の拡大、細胞分析のためのマイクロ流体技術やラボオンチップ技術の進歩、ポイントオブケアや分散型検査ソリューションの重視の高まりが含まれます。

個別化医療がますます重視されるようになったことで、細胞溶解と分画市場は今後数年間で大きく成長する見通しです。個別化医療は進化する医療アプローチであり、個人の遺伝子プロファイルを活用して効果的に病気を診断・治療します。これは、各患者のユニークな特性、特に遺伝的構成に焦点を当てて、医療上の決定や治療を調整することを意味します。細胞溶解と分画は、プレシジョン・メディシンの基本的な構成要素であり、タンパク質、細胞小器官、核酸など、患者サンプルから特定の細胞内成分を分離・分析することを可能にします。この機能により、科学者やヘルスケア専門家は、疾患の根底にある分子メカニズムを解明し、各患者の異なる分子特性に基づいた個別化治療を開発することができます。特に、個別化医療連合（PMC）は、様々な疾患カテゴリーにおいて遺伝子検査製品や個別化医薬品の利用可能性が大幅に増加すると予測しており、ヘルスケアの展望を形成する上で個別化医療が極めて重要な役割を担っていることを強調しています。その結果、個別化医療がますます重視されるようになり、細胞溶解と分画市場の拡大を促進する主な要因となっています。

細胞溶解と分画市場の主要プレーヤーは、進化する市場競争において優位に立つため、先進的なソリューションの導入を積極的に進めています。このようなイノベーションの一例として、CGT（細胞・遺伝子治療）ウイルスベクター溶解キットの開発が挙げられ、ウイルスベクター溶解プロセスを合理化し、ワークフローの標準化と安全性を高めるように設計されています。これらのキットは、アデノ随伴ウイルス（AAV）溶解のための簡略化された手法を提供し、細胞溶解液から複数の血清型にわたるウイルス力価を正確に定量することを容易にします。例えば、サンプルおよびアッセイ技術のリーディングプロバイダーであるQIAGENは、2023年7月にCGT Viral Vector Lysis Kitを発売しました。この革新的なソリューションは、バイオ医薬品業界向けのQIAGENの広範なデジタルPCRポートフォリオを補完するものであり、市場の進化する要求に応えるために細胞溶解と分画テクノロジーを進化させるという当社のコミットメントを明確に示すものです。ウイルスベクター溶解のための堅牢で標準化されたソリューションを提供することで、QIAGENのような企業は、個別化医療の広範な採用を促進し、細胞溶解と分画市場の成長を促進する上で極めて重要な役割を果たす態勢を整えています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の細胞溶解と分画市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場抑制要因
  • 世界の細胞溶解と分画市場の実績：規模と成長、2018年～2023年
  • 世界の細胞溶解と分画市場の予測：規模と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の細胞溶解と分画市場：タイプ別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 哺乳類細胞
  • 微生物細胞
  • 世界の細胞溶解と分画市場：用途別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 核酸の精製と分離
  • タンパク質の精製と分離
  • 世界の細胞溶解と分画市場：エンドユーザー別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • ラボおよび研究所
  • バイオ医薬品
  • バイオテクノロジー企業

第7章 地域別・国別分析

  • 世界の細胞溶解と分画市場：地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 世界の細胞溶解と分画市場：国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 細胞溶解と分画市場：競合情勢
  • 細胞溶解と分画市場：企業プロファイル
    • Hoffmann-La Roche Ltd
    • Merck & Co. Inc.
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Becton, Dickinson and Company

第31章 その他の大手企業と革新的企業

  • Lonza Group AG
  • Illumina Inc.
  • Beckman Coulter Inc.
  • PerkinElmer Inc.
  • IDEX Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Eppendorf AG
  • Miltenyi Biotec B.V. & Co. KG
  • Promega Corporation
  • Takara Bio Inc.
  • Abcam plc
  • Cell Signaling Technology Inc.
  • BioVision Inc.
  • Diagenode LLC

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r16790

Cell lysis and fractionation are interconnected methods utilized in biological research to rupture cells and segregate their constituents for analysis. Cell lysis involves disintegrating a cell to discharge its contents, comprising proteins, nucleic acids, and additional biological elements. Conversely, fractionation entails segregating cellular components based on their size, shape, density, charge, or other attributes.

The primary types of cell lysis and fractionation involve mammalian cells and microbial cells. Mammalian cells are eukaryotic cells derived from mammals, commonly used in cell culture and the biomanufacturing of therapeutic proteins and viral vaccines. These cells find applications in various processes such as nucleic acid and protein purification, and are utilized by research laboratories, institutes, biopharmaceutical, and biotechnology companies.

The cell lysis and fractionation market research report is one of a series of new reports from The Business Research Company that provides cell lysis and fractionation market statistics, including cell lysis and fractionation industry global market size, regional shares, competitors with cell lysis and fractionation market share, detailed cell lysis and fractionation market segments, market trends, and opportunities, and any further data you may need to thrive in the cell lysis and fractionation industry. This cell lysis and fractionation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell lysis and fractionation market size has grown strongly in recent years. It will grow from $3.14 billion in 2023 to $3.42 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The expansion during the historical period can be credited to the rise in investments in life science research, heightened emphasis on personalized medicine, widespread occurrence of diseases, technological progressions in cell lysis and fractionation techniques, and the increasing demand for biopharmaceuticals and biotechnology products.

The cell lysis and fractionation market size is expected to see strong growth in the next few years. It will grow to $4.57 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%. The expansion anticipated in the forecast period is driven by a heightened focus on personalized medicine, augmented government funding for research, substantial demand for efficient cell lysis and fractionation techniques, technological advancements in genomics and proteomics, and an escalating prevalence of chronic and infectious diseases. Significant trends expected in the forecast period encompass sustained growth in the adoption of personalized medicine methodologies, greater incorporation of automation and robotics in lysis and fractionation procedures, broadening applications in clinical diagnostics and drug development, advancements in microfluidics and lab-on-a-chip technologies for cell analysis, and an increased emphasis on point-of-care and decentralized testing solutions.

The increasing emphasis on personalized medicine is poised to drive significant growth within the cell lysis and fractionation markets in the coming years. Personalized medicine, an evolving medical approach, leverages an individual's genetic profile to diagnose and treat diseases effectively. It entails tailoring medical decisions and therapies to each patient's unique characteristics, particularly focusing on their genetic makeup. Cell lysis and fractionation serve as fundamental components of precision medicine, enabling the isolation and analysis of specific subcellular components from patient samples, including proteins, organelles, and nucleic acids. This capability empowers scientists and healthcare professionals to delve into the molecular mechanisms underlying diseases and develop personalized treatments based on each patient's distinct molecular traits. Notably, the Personalized Medicine Coalition (PMC) projects a significant rise in the availability of genetic testing products and personalized medicines across various disease categories, further underscoring the pivotal role of personalized medicine in shaping the landscape of healthcare. Consequently, the increasing emphasis on personalized medicine emerges as a primary driver propelling the expansion of the cell lysis and fractionation markets.

Key players within the cell lysis and fractionation markets are actively pursuing the introduction of advanced solutions to gain a competitive edge in the evolving landscape. One such innovation is exemplified by the development of CGT (cell and gene therapy) viral vector lysis kits, designed to streamline viral vector lysis processes and enhance workflow standardization and safety. These kits offer a simplified methodology for Adeno-associated virus (AAV) lysis, facilitating precise quantification of virus titers across multiple serotypes from cell lysates. For instance, QIAGEN, a leading provider of sample and assay technologies, launched the CGT Viral Vector Lysis Kit in July 2023, aimed at enabling precise and uniform virus titer quantification for various serotypes. Complementing QIAGEN's extensive digital PCR portfolio for the biopharmaceutical industry, this innovative solution underscores the company's commitment to advancing cell lysis and fractionation technologies to meet the evolving demands of the market. By providing robust and standardized solutions for viral vector lysis, companies such as QIAGEN are poised to play a pivotal role in facilitating the broader adoption of personalized medicine and driving growth within the cell lysis and fractionation markets.

In December 2022, MilliporeSigma, a pharmaceutical company based in the United States, finalized the acquisition of Erbi Biosystems Inc. for an undisclosed sum. Through this strategic move, MilliporeSigma aims to bolster its portfolio and expertise in the bioreactors and cell culture technologies sector. Erbi Biosystems is renowned as the developer of the Breez platform technology, a 2 ml micro-bioreactor platform known for its micro-scale, fully automated, and functionally closed system. Erbi Biosystems Inc., based in the United States, specializes in providing microfluidic solutions designed to facilitate efficient and controlled cell lysis and fractionation..

Major companies operating in the cell lysis and fractionation market report are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.

North America was the largest region in the cell lysis and fractionation market in 2023. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell lysis and fractionation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell lysis and fractionation market consists of revenues earned by entities by providing cellular contents extraction, cytoplasmic separation, and cell disruption. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell lysis and fractionation market also includes sales of cell lysis instruments, cell lysis reagents, and consumables. Values in this market are 'factory gate' values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Lysis And Fractionation Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell lysis and fractionation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell lysis and fractionation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell lysis and fractionation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Mammalian Cells; Microbial Cells
  • 2) By Application: Nucleic Acid Purification And Isolation; Protein Purification And Isolation
  • 3) By End-User: Research Laboratories And Institutes; Biopharmaceutical; Biotechnology Companies
  • Companies Mentioned: Hoffmann-La Roche Ltd; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton, Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell Lysis And Fractionation Market Characteristics

3. Cell Lysis And Fractionation Market Trends And Strategies

4. Cell Lysis And Fractionation Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cell Lysis And Fractionation Market Size and Growth

  • 5.1. Global Cell Lysis And Fractionation Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cell Lysis And Fractionation Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cell Lysis And Fractionation Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cell Lysis And Fractionation Market Segmentation

  • 6.1. Global Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Mammalian Cells
  • Microbial Cells
  • 6.2. Global Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Nucleic Acid Purification And Isolation
  • Protein Purification And Isolation
  • 6.3. Global Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Research Laboratories And Institutes
  • Biopharmaceutical
  • Biotechnology Companies

7. Cell Lysis And Fractionation Market Regional And Country Analysis

  • 7.1. Global Cell Lysis And Fractionation Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cell Lysis And Fractionation Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cell Lysis And Fractionation Market

  • 8.1. Asia-Pacific Cell Lysis And Fractionation Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cell Lysis And Fractionation Market

  • 9.1. China Cell Lysis And Fractionation Market Overview
  • 9.2. China Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cell Lysis And Fractionation Market

  • 10.1. India Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cell Lysis And Fractionation Market

  • 11.1. Japan Cell Lysis And Fractionation Market Overview
  • 11.2. Japan Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cell Lysis And Fractionation Market

  • 12.1. Australia Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cell Lysis And Fractionation Market

  • 13.1. Indonesia Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cell Lysis And Fractionation Market

  • 14.1. South Korea Cell Lysis And Fractionation Market Overview
  • 14.2. South Korea Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cell Lysis And Fractionation Market

  • 15.1. Western Europe Cell Lysis And Fractionation Market Overview
  • 15.2. Western Europe Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cell Lysis And Fractionation Market

  • 16.1. UK Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cell Lysis And Fractionation Market

  • 17.1. Germany Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cell Lysis And Fractionation Market

  • 18.1. France Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cell Lysis And Fractionation Market

  • 19.1. Italy Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cell Lysis And Fractionation Market

  • 20.1. Spain Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cell Lysis And Fractionation Market

  • 21.1. Eastern Europe Cell Lysis And Fractionation Market Overview
  • 21.2. Eastern Europe Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cell Lysis And Fractionation Market

  • 22.1. Russia Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cell Lysis And Fractionation Market

  • 23.1. North America Cell Lysis And Fractionation Market Overview
  • 23.2. North America Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cell Lysis And Fractionation Market

  • 24.1. USA Cell Lysis And Fractionation Market Overview
  • 24.2. USA Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cell Lysis And Fractionation Market

  • 25.1. Canada Cell Lysis And Fractionation Market Overview
  • 25.2. Canada Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cell Lysis And Fractionation Market

  • 26.1. South America Cell Lysis And Fractionation Market Overview
  • 26.2. South America Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cell Lysis And Fractionation Market

  • 27.1. Brazil Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cell Lysis And Fractionation Market

  • 28.1. Middle East Cell Lysis And Fractionation Market Overview
  • 28.2. Middle East Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cell Lysis And Fractionation Market

  • 29.1. Africa Cell Lysis And Fractionation Market Overview
  • 29.2. Africa Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cell Lysis And Fractionation Market Competitive Landscape And Company Profiles

  • 30.1. Cell Lysis And Fractionation Market Competitive Landscape
  • 30.2. Cell Lysis And Fractionation Market Company Profiles
    • 30.2.1. Hoffmann-La Roche Ltd
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck & Co. Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Danaher Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Becton, Dickinson and Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Cell Lysis And Fractionation Market Other Major And Innovative Companies

  • 31.1. Lonza Group AG
  • 31.2. Illumina Inc.
  • 31.3. Beckman Coulter Inc.
  • 31.4. PerkinElmer Inc.
  • 31.5. IDEX Corporation
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. QIAGEN NV
  • 31.8. Eppendorf AG
  • 31.9. Miltenyi Biotec B.V. & Co. KG
  • 31.10. Promega Corporation
  • 31.11. Takara Bio Inc.
  • 31.12. Abcam plc
  • 31.13. Cell Signaling Technology Inc.
  • 31.14. BioVision Inc.
  • 31.15. Diagenode LLC

32. Global Cell Lysis And Fractionation Market Competitive Benchmarking

33. Global Cell Lysis And Fractionation Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cell Lysis And Fractionation Market

35. Cell Lysis And Fractionation Market Future Outlook and Potential Analysis

  • 35.1 Cell Lysis And Fractionation Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Cell Lysis And Fractionation Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Cell Lysis And Fractionation Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer